Oncolytics Biotech (ONCY) Non Operating Interest Expenses (2009 - 2025)
Oncolytics Biotech's (ONCY) quarterly Non Operating Interest Expenses came in at $28338.8 in Q3 2025, down 38.64% year-over-year from $46182.4 in Q3 2024, and down 38.64% quarter-over-quarter from $46182.4 in Q3 2024.
Powered by 
Analysis
Oncolytics Biotech (ONCY) Non Operating Interest Expenses (2009 - 2025) Analysis & Trends
Oncolytics Biotech (ONCY) has reported Non Operating Interest Expenses for 12 consecutive years, with $28338.8 the latest figure, recorded in Q3 2025.
- On a quarterly basis, Non Operating Interest Expenses fell 38.64% year-over-year to $28338.8 in Q3 2025; TTM through Sep 2025 was $156939.1, a 0.93% increase from a year earlier, with the FY2018 full-year figure at $131444.0, up 28.35% from the prior year.
- Non Operating Interest Expenses was $28338.8 for Q3 2025 at Oncolytics Biotech, down from $46182.4 in the prior quarter.
- Over five years, Non Operating Interest Expenses peaked at $46182.4 in Q3 2024 and troughed at $28338.8 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 673.00 Mn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 247.00 Mn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 11.00 Mn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | -1.00 Mn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 82.05 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | Oncolytics Biotech | 91.92 Mn | 91.92 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 28,338.77 |
| Sep 30, 2024 | 46,182.36 |
| Sep 30, 2018 | 61,880.00 |
| Jun 30, 2018 | 20,538.00 |
| Mar 31, 2018 | 26,890.00 |
| Sep 30, 2017 | 31,759.00 |
| Jun 30, 2017 | 14,163.00 |
| Mar 31, 2017 | 50,715.00 |
| Sep 30, 2016 | 31,691.00 |
| Mar 31, 2016 | 69,621.00 |
| Sep 30, 2015 | 52,756.00 |
| Mar 31, 2015 | 56,435.00 |
| Dec 31, 2014 | 32,213.00 |
| Sep 30, 2014 | 39,937.00 |
| Jun 30, 2014 | 50,253.00 |
| Mar 31, 2014 | 87,987.00 |
| Dec 31, 2013 | 80,679.00 |
| Sep 30, 2013 | 110,479.00 |
| Jun 30, 2013 | 105,368.00 |
| Mar 31, 2013 | 74,959.00 |